BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our Industry eNewsletter FREE email:    
 Investor News
Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings
Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions 
Start-Ups
IPO News
IPO
 


Clinical - Post-Approval (Research/Post Marketing/Phase IV)
Saga Continues: Roche (RHHBY)'s Tamiflu No Better Than Tylenol At "Fighting Flu" 4/11/2014 6:30:29 AM    More...
Dendreon Corporation (DNDN) Release: Immune Responses Enhanced And Sustained When PROVENGE® (Sipuleucel-T) Is Given After Androgen Deprivation Therapy In Biochemically-Recurrent Prostate Cancer 4/11/2014 8:15:28 AM    More...
Gilead Sciences, Inc. (GILD)’s Sovaldi® Demonstrates Efficacy And Safety Among Chronic Hepatitis C Patients With Advanced Liver Disease 4/11/2014 8:09:37 AM    More...
FDA Grants Breakthrough Status Designation To Novartis AG (NVS)' Meningitis B Vaccine 4/8/2014 6:37:50 AM    More...
H. Lundbeck A/S (LUN.CO) Release: Treatment With Once-Monthly Abilify Maintena® (Aripiprazole) Significantly Reduces Hospitalisation Rates For Patients With Schizophrenia Compared With Daily Oral Antipsychotics 4/7/2014 9:11:37 AM    More...
Bristol-Myers Squibb Company (BMY)'s Eliquis® Works As Well As Pfizer Inc. (PFE)'s In Head-To-Head Subanalysis Study 3/27/2014 6:58:32 AM    More...
Roche (RHHBY)-Backed Study Finds Tamiflu Saved Lives In Flu Pandemic 3/19/2014 7:21:07 AM    More...
uniQure And Chiesi Farmaceutici SpA Announce Six Year Follow-up Data from Glybera® Treated Patients 3/17/2014 8:58:30 AM    More...
Pfizer Inc. (PFE) Vaccine Prevents Pneumonia In Landmark Study 3/12/2014 8:38:10 AM    More...
Merck & Co., Inc. (MRK) Release: New 96-Week ACTG Study Results Presented At CROI 2014; First Large Study Comparing ISENTRESS® (Raltegravir) Regimen To Two Protease Inhibitor Regimens In Previously Untreated Adults With HIV-1 3/5/2014 11:00:18 AM    More...
Janssen Pharmaceutica N.V. Release: New Data Show XEPLION® Significantly Delays Time To Relapse Compared To Treatment As Usual With Oral Antipsychotic Monotherapy 3/4/2014 9:59:54 AM    More...
Pfizer Inc. (PFE) Revs Up For Testing Of Over-The-Counter Lipitor 3/3/2014 8:19:49 AM    More...
Low-Level Usage Of Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Actos May Still Hold Bladder Cancer Risk: Study 2/27/2014 8:21:19 AM    More...
Baxter International, Inc. (BAX) Presents Data At EAHAD From Long-Term Outcomes Registry Reinforcing Prophylaxis Treatment Experience With ADVATE 2/27/2014 10:00:16 AM    More...
Pfizer Inc. (PFE) Touts Positive Results In Pneumonia Vaccine Post-Approval Study 2/24/2014 6:59:28 AM    More...
1234567
 

//-->